Degradation of mescaline by amine oxidases. 1958

E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS

UI MeSH Term Description Entries
D008635 Mescaline Hallucinogenic alkaloid isolated from the flowering heads (peyote) of Lophophora (formerly Anhalonium) williamsii, a Mexican cactus used in Indian religious rites and as an experimental psychotomimetic. Among its cellular effects are agonist actions at some types of serotonin receptors. It has no accepted therapeutic uses although it is legal for religious use by members of the Native American Church. Mezcalin,Peyote,Trimethoxyphenethylamine,3,4,5-Trimethoxyphenethylamine
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
April 1966, Biochemical pharmacology,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
January 1968, Therapie,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
April 2001, Fundamental & clinical pharmacology,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
January 1971, Methods of biochemical analysis,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
January 2002, Zhurnal evoliutsionnoi biokhimii i fiziologii,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
January 1995, Archives of biochemistry and biophysics,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
December 1963, Canadian Medical Association journal,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
December 1988, Pharmacological research communications,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
March 1982, British journal of obstetrics and gynaecology,
E A ZELLER, and J BARSKY, and E R BERMAN, and M S CHERKAS, and J R FOUTS
January 2004, Neurotoxicology,
Copied contents to your clipboard!